The Food and Drug Administration issued its final report on ways to combat what it described as "the growing public health problem of counterfeit prescriptions." The FDA called for the use of new technologies to track drugs and for state-by-state adoption and enforcement of strong anticounterfeiting laws and regulations. The drug distribution industry and the American Medical Association praised the report. Among other things, the Healthcare Distribution Management Association called for all 50 states to adopt uniform standards to prevent illegitimate distributors from conducting business. The AMA said physicians have a key communications role to play in stemming counterfeiting and urged the U.S. to act aggressively by adopting new technologies and improving business practices. Read the FDA report. -- by Cinda Becker
FDA proposes ways to stop drug counterfeiting
Send us a letter
Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.